Cardiology >
Prevention
News, opinions and meeting coverage in cardiology.
Droxidopa for OH Slammed by FDA Reviewers
SILVER SPRING, Md. -- Droxidopa (Northera) is getting a second look by an FDA advisory committee for the treatment of orthostatic hypotension stemming from neurological disorders like Parkinson's disease, but an agency review doesn't look promising for approval.
Jan 13, 2014
10 Questions: John P. Erwin, MD
What's the biggest barrier to practicing medicine today? That's just the first of 10 questions the 鶹ý staff is asking leading clinicians and researchers to get their personal views on their chosen profession. In this series we share their uncensored responses. Here, answers from John P. Erwin, MD, of Scott & White Healthcare in Temple, Texas.
Dec 04, 2013
Cardiologist Who Revealed Echo Errors Out of a Job
MILWAUKEE -- A cardiologist whose research at a national medical meeting revealed that other doctors at her hospital were misreading a substantial number of diagnostic echocardiograms has been fired by that hospital, the Journal Sentinel and 鶹ý have learned.
Jan 14, 2011
ACC: Triglycerides Decreased with Rosuvastatin Therapy
ATLANTA -- In a study that specifically scrutinized the effects of statin therapy on triglycerides, researchers said that rosuvastatin (Crestor) significantly reduced the blood lipid that has been linked to coronary artery disease better than placebo.
Mar 15, 2010